File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1158/1078-0432.CCR-10-1800
- Scopus: eid_2-s2.0-79953330808
- PMID: 21350001
- WOS: WOS:000289054100010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer
Title | Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer |
---|---|
Authors | |
Issue Date | 2011 |
Citation | Clinical Cancer Research, 2011, v. 17 n. 7, p. 1722-1730 How to Cite? |
Abstract | Purpose: To investigate expression, regulation, potential role and targets of miR-195 and miR-497 in breast cancer. Experimental Design: The expression patterns of miR-195 and miR-497 were initially examined in breast cancer tissues and cell lines by Northern blotting and quantitative real-time PCR. Combined bisulfite restriction analysis and bisulfite sequencing were carried out to study the DNA methylation status of miR-195 and miR-497 genes. Breast cancer cells stably expressing miR-195 and miR-497 were established to study their role and targets. Finally, normal, fibroadenoma and breast cancer tissues were employed to analyze the correlation between miR-195/497 levels and malignant stages of breast tumor tissues. Results: MiR-195 and miR-497 were significantly downregulated in breast cancer. The methylation state of CpG islands upstream of the miR-195/497 gene was found to be responsible for the downregulation of both miRNAs. Forced expression of miR-195 or miR-497 suppressed breast cancer cell proliferation and invasion. Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497. miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer. Conclusions: Our data imply that both miR-195 and miR-497 play important inhibitory roles in breast cancer malignancy and may be the potential therapeutic and diagnostic targets. ©2011 AACR. |
Persistent Identifier | http://hdl.handle.net/10722/168518 |
ISSN | 2023 Impact Factor: 10.0 2023 SCImago Journal Rankings: 4.623 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, D | en_US |
dc.contributor.author | Zhao, Y | en_US |
dc.contributor.author | Liu, C | en_US |
dc.contributor.author | Chen, X | en_US |
dc.contributor.author | Qi, Y | en_US |
dc.contributor.author | Jiang, Y | en_US |
dc.contributor.author | Zou, C | en_US |
dc.contributor.author | Zhang, X | en_US |
dc.contributor.author | Liu, S | en_US |
dc.contributor.author | Wang, X | en_US |
dc.contributor.author | Zhao, D | en_US |
dc.contributor.author | Sun, Q | en_US |
dc.contributor.author | Zeng, Z | en_US |
dc.contributor.author | Dress, A | en_US |
dc.contributor.author | Lin, MC | en_US |
dc.contributor.author | Kung, HF | en_US |
dc.contributor.author | Rui, H | en_US |
dc.contributor.author | Liu, LZ | en_US |
dc.contributor.author | Mao, F | en_US |
dc.contributor.author | Jiang, BH | en_US |
dc.contributor.author | Lai, L | en_US |
dc.date.accessioned | 2012-10-08T03:19:56Z | - |
dc.date.available | 2012-10-08T03:19:56Z | - |
dc.date.issued | 2011 | en_US |
dc.identifier.citation | Clinical Cancer Research, 2011, v. 17 n. 7, p. 1722-1730 | en_US |
dc.identifier.issn | 1078-0432 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/168518 | - |
dc.description.abstract | Purpose: To investigate expression, regulation, potential role and targets of miR-195 and miR-497 in breast cancer. Experimental Design: The expression patterns of miR-195 and miR-497 were initially examined in breast cancer tissues and cell lines by Northern blotting and quantitative real-time PCR. Combined bisulfite restriction analysis and bisulfite sequencing were carried out to study the DNA methylation status of miR-195 and miR-497 genes. Breast cancer cells stably expressing miR-195 and miR-497 were established to study their role and targets. Finally, normal, fibroadenoma and breast cancer tissues were employed to analyze the correlation between miR-195/497 levels and malignant stages of breast tumor tissues. Results: MiR-195 and miR-497 were significantly downregulated in breast cancer. The methylation state of CpG islands upstream of the miR-195/497 gene was found to be responsible for the downregulation of both miRNAs. Forced expression of miR-195 or miR-497 suppressed breast cancer cell proliferation and invasion. Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497. miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer. Conclusions: Our data imply that both miR-195 and miR-497 play important inhibitory roles in breast cancer malignancy and may be the potential therapeutic and diagnostic targets. ©2011 AACR. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Clinical Cancer Research | en_US |
dc.subject.mesh | 3' Untranslated Regions | en_US |
dc.subject.mesh | Base Sequence | en_US |
dc.subject.mesh | Breast Neoplasms - Genetics - Metabolism - Pathology | en_US |
dc.subject.mesh | Cell Line, Tumor | en_US |
dc.subject.mesh | Cell Movement | en_US |
dc.subject.mesh | Cell Proliferation | en_US |
dc.subject.mesh | Cpg Islands | en_US |
dc.subject.mesh | Cyclin D1 - Metabolism | en_US |
dc.subject.mesh | Dna Methylation | en_US |
dc.subject.mesh | Down-Regulation | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Gene Silencing | en_US |
dc.subject.mesh | Genes, Reporter | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Luciferases, Renilla - Biosynthesis - Genetics | en_US |
dc.subject.mesh | Micrornas - Genetics - Metabolism | en_US |
dc.subject.mesh | Neoplasm Invasiveness | en_US |
dc.subject.mesh | Proto-Oncogene Proteins C-Raf - Metabolism | en_US |
dc.subject.mesh | Restriction Mapping | en_US |
dc.title | Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lin, MC:mcllin@hkucc.hku.hk | en_US |
dc.identifier.authority | Lin, MC=rp00746 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1158/1078-0432.CCR-10-1800 | en_US |
dc.identifier.pmid | 21350001 | - |
dc.identifier.scopus | eid_2-s2.0-79953330808 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-79953330808&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 17 | en_US |
dc.identifier.issue | 7 | en_US |
dc.identifier.spage | 1722 | en_US |
dc.identifier.epage | 1730 | en_US |
dc.identifier.isi | WOS:000289054100010 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Li, D=46761212500 | en_US |
dc.identifier.scopusauthorid | Zhao, Y=24170406900 | en_US |
dc.identifier.scopusauthorid | Liu, C=46761188300 | en_US |
dc.identifier.scopusauthorid | Chen, X=24170717900 | en_US |
dc.identifier.scopusauthorid | Qi, Y=24171887800 | en_US |
dc.identifier.scopusauthorid | Jiang, Y=36673053600 | en_US |
dc.identifier.scopusauthorid | Zou, C=36505538900 | en_US |
dc.identifier.scopusauthorid | Zhang, X=46761651600 | en_US |
dc.identifier.scopusauthorid | Liu, S=46761178500 | en_US |
dc.identifier.scopusauthorid | Wang, X=46761537900 | en_US |
dc.identifier.scopusauthorid | Zhao, D=35147395100 | en_US |
dc.identifier.scopusauthorid | Sun, Q=35206599000 | en_US |
dc.identifier.scopusauthorid | Zeng, Z=7402647166 | en_US |
dc.identifier.scopusauthorid | Dress, A=23145163000 | en_US |
dc.identifier.scopusauthorid | Lin, MC=7404816359 | en_US |
dc.identifier.scopusauthorid | Kung, HF=7402514190 | en_US |
dc.identifier.scopusauthorid | Rui, H=7005244652 | en_US |
dc.identifier.scopusauthorid | Liu, LZ=35074383300 | en_US |
dc.identifier.scopusauthorid | Mao, F=36461384700 | en_US |
dc.identifier.scopusauthorid | Jiang, BH=35264238500 | en_US |
dc.identifier.scopusauthorid | Lai, L=12445800200 | en_US |
dc.identifier.issnl | 1078-0432 | - |